Atopic Dermatitis Market, By Drug Class (Corticosteroids, Emollients/Moisturizers, IL-4 & PDE4 Inhibitors, Calcineurin Inhibitors Antibiotics, and Other Drug Classes), By Type of Administration (Topical, Oral, and Injectable), By Prescription Type (Over-t

Atopic Dermatitis Market, By Drug Class (Corticosteroids, Emollients/Moisturizers, IL-4 & PDE4 Inhibitors, Calcineurin Inhibitors Antibiotics, and Other Drug Classes), By Type of Administration (Topical, Oral, and Injectable), By Prescription Type (Over-the-counter (OTC) and Prescription), and By Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Atopic dermatitis (AD), or eczema, is a chronic condition that causes dry, itchy, and inflamed skin. It is the most common chronic skin disease and is genetically transmitted. It can be irritating but it is not contagious. Atopic dermatitis is chronic condition and tends to flare sometimes. It’s common in young children but can occur at any age. There is no cure for atopic dermatitis, and many people have troubling controlling it.

Market Dynamics:

Increasing prevalence of atopic dermatitis across the world, rise in awareness among people about atopic dermatitis, growing government expenditure regarding atopic dermatitis, increase in focus on the development of novel therapeutics, and outbreak of COVID-19 (global pandemic) are major factors expected to drive growth of the global atopic dermatitis market.

For instance, in February 2022, Evelo Biosciences reported that the first patient has been dosed in EDP1815-207, its Phase 2 randomized clinical trial of EDP1815 for the treatment of patients with mild, moderate, and severe atopic dermatitis.

Moreover, in October 2022, LEO Pharma A/S, launched AD Days Around the World, a global disease awareness campaign that highlights the experiences of people living with atopic dermatitis (AD); the most common form of atopic dermatitis.

Key features of the study:

• This report provides in-depth analysis of the global atopic dermatitis market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2022–2028), considering 2021 as the base year.
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global atopic dermatitis market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study include Pfizer Inc., Novartis AG, Nestle, LEO Pharma AS, Encore Dermatology Inc., GlaxoSmithKline PLC, Allergan PLC, AbbVie Inc., Regeneron Pharmaceuticals Inc., and Bausch Health Companies Inc., among others.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• The global atopic dermatitis market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global atopic dermatitis market.

• Global Atopic Dermatitis Market, By Drug Class:
• Corticosteroids
• Emollients/Moisturizers
• IL-4 & PDE4 Inhibitors
• Calcineurin Inhibitors Antibiotics
• Other Drug Classes
• Global Atopic Dermatitis Market, By Type of Administration:
• Topical
• Oral
• Injectable
• Global Atopic Dermatitis Market, By Prescription Type:
• Over-the-counter (OTC)
• Prescription
• Global Atopic Dermatitis Market, By Geography:
• North America
• Europe
• Asia-Pacific
• Middle East and Africa
• South America
• Company Profiles:
• Pfizer Inc.
• Novartis AG
• Nestle
• LEO Pharma AS
• Encore Dermatology Inc.
• GlaxoSmithKline PLC
• Allergan PLC
• AbbVie Inc.
• Regeneron Pharmaceuticals Inc.
• Bausch Health Companies Inc.